Literature DB >> 20033845

Association between posttraumatic stress disorder following myocardial infarction and liver enzyme levels: a prospective study.

Roland von Känel1, Chiara C Abbas, Stefan Begré, Marie-Louise Gander, Hugo Saner, Jean-Paul Schmid.   

Abstract

BACKGROUND: Research in rodents demonstrated that psychological stress increases circulating levels of alanine transaminase, aspartate transaminase, and alkaline phosphatase reflecting liver injury. Moreover, chronic posttraumatic stress disorder and transaminases predicted coronary heart disease. AIMS: To investigate the hypothesis that severity of posttraumatic stress disorder following myocardial infarction would prospectively relate to liver enzymes.
METHODS: Study participants were 24 patients (mean 59+/-7 years, 79% men) with an interviewer-rated diagnosis of posttraumatic stress disorder caused by an index myocardial infarction 3+/-3 months before. After a mean follow-up of 26+/-6 months, patients had a clinical interview to reassess posttraumatic stress disorder severity, a medical history, and blood collected to determine liver enzymes.
RESULTS: Total posttraumatic stress disorder symptoms assessed at study entry prospectively predicted plasma levels of alanine transaminase (r=.47, p=.031) and alkaline phosphatase (r=.57, p=.004), but not of aspartate transaminase (p=.15), controlling for follow-up duration and antidepressant use. Total posttraumatic stress disorder symptoms assessed at follow-up were associated with alanine transaminase (r=.72, p=.004), aspartate transaminase (r=.60, p=.018), and alkaline phosphatase (r=.64, p=.001) in the 16 patients who had maintained diagnostic posttraumatic stress disorder, but not in all 24 patients.
CONCLUSIONS: The severity of posttraumatic stress disorder following myocardial infarction was associated with mild increase in liver enzyme levels, suggesting that chronic psychological stress relates to hepatic damage in humans. This might help to explain the previously observed increased cardiovascular risk in chronically traumatized individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033845     DOI: 10.1007/s10620-009-1082-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  47 in total

1.  Changes in plasma norepinephrine to combat-related stimuli among Vietnam veterans with posttraumatic stress disorder.

Authors:  E B Blanchard; L C Kolb; A Prins; S Gates; G C McCoy
Journal:  J Nerv Ment Dis       Date:  1991-06       Impact factor: 2.254

Review 2.  Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis.

Authors:  Marie-Louise Meewisse; Johannes B Reitsma; Giel-Jan de Vries; Berthold P R Gersons; Miranda Olff
Journal:  Br J Psychiatry       Date:  2007-11       Impact factor: 9.319

3.  Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.

Authors:  Roger K Schindhelm; Jacqueline M Dekker; Giel Nijpels; Lex M Bouter; Coen D A Stehouwer; Robert J Heine; Michaela Diamant
Journal:  Atherosclerosis       Date:  2006-05-08       Impact factor: 5.162

4.  Trajectory of posttraumatic stress disorder caused by myocardial infarction: a two-year follow-up study.

Authors:  Chiara C Abbas; Jean-paul Schmid; Erika Guler; Lina Wiedemar; Stefan Begré; Hugo Saner; Ulrich Schnyder; Roland von Känel
Journal:  Int J Psychiatry Med       Date:  2009       Impact factor: 1.210

5.  Liver ultrastructure during acute stress.

Authors:  M Salas; B Tuchweber; P Kourounakis
Journal:  Pathol Res Pract       Date:  1980       Impact factor: 3.250

Review 6.  Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder.

Authors:  T O'Donnell; K M Hegadoren; N C Coupland
Journal:  Neuropsychobiology       Date:  2004       Impact factor: 2.328

7.  Effort-reward imbalance and physical health among Japanese workers in a recently downsized corporation.

Authors:  Masahiro Irie; Akizumi Tsutsumi; Izuru Shioji; Fumio Kobayashi
Journal:  Int Arch Occup Environ Health       Date:  2004-08-13       Impact factor: 3.015

Review 8.  Does stress exacerbate liver diseases?

Authors:  Yoichi Chida; Nobuyuki Sudo; Chiharu Kubo
Journal:  J Gastroenterol Hepatol       Date:  2006-01       Impact factor: 4.029

9.  Liver biochemistry abnormalities in a quaternary care lipid clinic database.

Authors:  Holly A R Wiesinger; J Shah; A White; E M Yoshida; J Frohlich; S Sirrs; S Gill; M F Byrne
Journal:  Ann Hepatol       Date:  2008 Jan-Mar       Impact factor: 2.400

10.  Prediction of coronary atherosclerotic disease with liver transaminase level.

Authors:  Peyman Adibi; Masoumeh Sadeghi; Majid Mahsa; Golnaz Rozati; Masood Mohseni
Journal:  Liver Int       Date:  2007-09       Impact factor: 5.828

View more
  4 in total

1.  Identifying causal regulatory SNPs in ChIP-seq enhancers.

Authors:  Di Huang; Ivan Ovcharenko
Journal:  Nucleic Acids Res       Date:  2014-12-17       Impact factor: 16.971

2.  Coping Strategies Influence Cardiometabolic Risk Factors in Chronic Psychological Stress: A Post Hoc Analysis of A Randomized Pilot Study.

Authors:  Deborah Armborst; Norman Bitterlich; Birgit Alteheld; Daniela Rösler; Christine Metzner; Roswitha Siener
Journal:  Nutrients       Date:  2021-12-24       Impact factor: 5.717

3.  Phenotypically Determined Liver Dysfunction in a Wistar Rat Model of Post-Traumatic Stress Disorder.

Authors:  M V Kondashevskaya; K A Artem'yeva; V V Aleksankina; D A Areshidze; M A Kozlova; L A Makartseva
Journal:  J Evol Biochem Physiol       Date:  2022-08-28       Impact factor: 1.621

4.  Intermittent Hypoxic Conditioning Alleviates Post-Traumatic Stress Disorder-Induced Damage and Dysfunction of Rat Visceral Organs and Brain.

Authors:  Eugenia B Manukhina; Vadim E Tseilikman; Marina N Karpenko; Nina S Pestereva; Olga B Tseilikman; Maria V Komelkova; Marina V Kondashevskaya; Anna V Goryacheva; Maxim S Lapshin; Pavel O Platkovskii; Alexey P Sarapultsev; Anatoly V Alliluev; H Fred Downey
Journal:  Int J Mol Sci       Date:  2020-01-05       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.